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Abstract
Background:  POU5F1 expression is required to maintain stem cell pluripotency and for
primordial germ cells to retain proliferative capability in embryonic development. Recent evidence
suggests that POU5F1 may also be a testicular germ cell carcinoma (TGCC) oncogene, and POU5F1
variation may influence TGCC risk. As an important first step to a genetic association study, we
sought to identify all common sequence variants in an 11.3 kb region containing POU5F1, and to
describe the linkage disequilibrium patterns, using DNA from individuals of African-descent (AD)
and European-descent (ED).
Results: A higher number of polymorphisms was observed in the AD (n = 102) versus ED (n =
82) population. Among the 41 observed haplotypes, 21 (51%) and 12 (29%) were unique to the AD
and ED populations, respectively, while 8 (20%) were observed in both. The number of tagging
polymorphisms necessary to explain at least 80% of common variation (minor allele frequency ≥
0.10) due to the remaining untyped polymorphisms was 17 for an AD and 10 for an ED population,
providing a 4.0- and 7.0-fold gain in genotyping efficiency for characterizing nucleotide variation,
respectively.
Conclusion: POU5F1 is highly polymorphic, however a smaller subset of polymorphisms can tag
the observed genetic variation with little loss of information.
Background
Mammalian totipotent cells, including the zygote and first
few cells of its cleavage, have two important characteris-
tics, i. they are able to maintain a high rate of karyotypic
normal cell division, and ii. they can differentiate into
every cell and tissue type throughout the organism.
POU5F1 is a member of the POU (Pit-Oct-Unc) domain
transcription factor family that activates expression of tar-
get genes by binding to octameric consensus sequences
[1]. POU5F1 is highly expressed in these totipotent cells
but is down regulated during gastrulation and in the cells
that comprise the trilaminar embryo, with the exception
of undifferentiated embryonic stem cells and the primor-
dial germ cells [2]. POU5F1 is associated with stem cell
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pluripotency in a somewhat quantitative manner, with
less than normal levels driving cells to differentiation [3].
Methylation of regulatory sequences appears to be a prin-
cipal mechanism through which POU5F1 expression is
shut-down in non-germ cell embryonic tissue; primordial
germ cells have mechanisms (as yet undefined) that pre-
vent POU5F1 methylation.
There is growing evidence that POU5F1 may be important
in testicular germ cell cancer (TGCC). POU5F1 is highly
expressed in nearly all adult seminomas, embryonal cell
carcinomas, and testicular carcinoma in situ (CIS), but
not childhood TGCC or spermatocytic carcinomas, or
non-germ cell testicular cancers [4,5]. Gidekel et al. found
that the induction of teratomas in mice, and anchorage-
independent growth of NIH3T3 cells (a characteristic of
cells transformed by known oncogenes, such as RAS),
were both related to POU5F1 expression in a positive
dose-response fashion; [2,6] this feature is reminiscent of
the quantitative relationship between expression and
pluripotency maintenance [3]. Notably, the efficiency of
the POU5F1 effect on NIH3T3 cells was comparable to
that of the RAS oncogene in the same experimental set-
ting. Additionally, the POU5F1 binding domain was
essential for this phenotype [6] Thus, POU5F1 appears
likely to be a TGCC oncogene.
The gene encoding POU5F1 (POU5F1) is located on chro-
mosome 6, approximately 130 kbs telomeric of the HLA-
C locus and 0.6 kb centromeric of the TCF19 locus.
POU5F1 encodes two isoforms, isoform 1 (also known as
OCT-3A) and isoform 2 (also known as OCT-3B), which
share 225 of their COOH-termini amino acids, differing
only in their first exon [7]. One hundred and eight poly-
morphisms have been reported to the National Center for
Biotechnology Information (NCBI) SNP Database (as of
November 13, 2006) [8] mapping to the POU5F1 region,
however, less than half of these have been validated by
multiple independent submissions or were found on
more than one chromosome. The International HapMap
Project, data release 21, phase II [9] has also genotyped
several polymorphisms in the POU5F1 region in individ-
uals from various populations, however, we do not know
to what extent these data represent the complete genetic
variation of the region. Given the important role of
POU5F1 in stem cell pluripotency, inherited variation in
POU5F1 conceivably could contribute to the risk of TGCC
and other complex phenotypes connected to stem cell
pluripotency, however, to date there have been no efforts
made to systematically re-sequence the entire gene region
to identify all common polymorphisms and describe their
linkage disequilibrium patterns.
We conducted this study to fill in several gaps in previous
knowledge concerning the genetic structure of POU5F1.
We have re-sequenced the region surrounding POU5F1
and identified all common polymorphic sites in a sample
of individuals of African- and European-decent, com-
pared our findings to what has been reported previously
in the NCBI SNP Database, mapped polymorphic sites to
evolutionarily conserved regions, statistically inferred
gene-wide haplotypes, and identified tagging polymor-
phisms and compared them to results based on the Inter-
national HapMap Project. This information will be useful
for future genetic association studies of POU5F1 and
TGCC or other relevant phenoytpes.
Results
Polymorphism identification
We identified 106 polymorphic loci in POU5F1 (Table 1).
In the following text, these loci are named according to
the number of bases from the first transcription start site,
with the major allele preceding the minor allele (major
allele > minor allele). Twenty-four of these loci were pol-
ymorphic in the AD population and monomorphic in the
ED population, and only four loci were polymorphic in
the ED population and monomorphic in the AD popula-
tion. Sixty-seven percent of the AD polymorphic/ED mon-
omorphic sites had a minor allele frequency (MAF) <0.10,
whereas this was observed in only 50% of the AD mono-
morphic/ED polymorphic sites. Ninety-three polymor-
phisms (88%) were diallelic single nucleotide
substitutions (SNPs) and 13 (12%) were insertion or dele-
tion polymorphisms (indels). Most polymorphisms were
located in the introns and flanking regions (Figure 1). Pol-
ymorphisms were found on an average of 1 in 103 base
pairs (bp) in the AD population and 1 in 127 bp in the ED
population, and a higher number of polymorphisms were
observed in the AD (n = 102) versus ED (n = 82) popula-
tion. No polymorphism deviated significantly (alpha <
0.05) from Hardy-Weinberg equilibrium. Seven polymor-
phisms were located in coding regions, however, only one
was a non-synonymous SNP (4466 T > G, rs3130932).
This SNP codes for a methionine to arginine amino acid
substitution in the start codon of isoform 2 of POU5F1,
and had a MAF of 0.23 in the AD population and 0.33 in
the ED population. Within the re-sequenced region,
excluding the two unscanned intronic segments, the NCBI
SNP Database contained records for 108 polymorphisms.
We verified 68 of these previously reported polymor-
phisms, failed to verify 40 polymorphisms, and identified
38 novel polymorphisms.
Comparative genomics
There were 20 highly conserved elements among verte-
brates identified in the re-sequenced region, with log-
odds scores ranging from 211 to 555 (Figure 1B.). Nine
polymorphisms were located in conserved regions in the
exons (67%) or 5' gene regions (33%): -2482 C > T
(rs17197241), -1611 G > A (rs3132520), -75 G > AB
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Table 1: Polymorphisms identified by POU5F1 re-sequencing
Site1 Location NCBI rsnumber2 Major allele Minor allele Minor Allele Frequency Site Location NCBI rsnumber Major allele Minor allele Minor Allele Frequency
AD3 ED AD ED
-2812 5' rs2269712 C T 0.15 0.22 1736 Intron 1 rs3130502 C T 0.17 0.20
-2730 5' rs2269713 T C 0.17 0.00 1825 Intron 1 rs9263809 T C 0.17 0.13
-2482 5' rs17197241 C T 0.08 0.00 1827 Intron 1 A G 0.02 0.07
-2411 5' rs6910473 C T 0.15 0.13 2524 Intron 1 C T 0.06 0.13
-2361 5' G A 0.02 0.00 2578 Intron 1 T A 0.02 0.00
-2344 5' rs1265158 G C 0.46 0.35 2625 Intron 1 A C 0.06 0.13
-2218 5' rs9501065 G A 0.21 0.04 2665 Intron 1 + - 0.38 0.46
-2135 5' rs885948 C T 0.33 0.46 2679 Intron 1 + - 0.06 0.13
-2121 5' rs6909939 C T 0.15 0.13 2697 Intron 1 A G 0.17 0.20
-1892 5' C T 0.02 0.00 3679 Intron 1 + - 0.17 0.20
-1827 5' G C 0.04 0.00 3738 Intron 1 + - 0.04 0.00
-1823 5' rs885949 A G 0.19 0.16 3781 Intron 1 T C 0.06 0.13
-1772 5' rs3132518 C G 0.42 0.36 3807 Intron 1 C T 0.17 0.13
-1755 5' rs885950 T G 0.40 0.48 3815 Intron 1 rs11965454 A G 0.15 0.00
-1694 5' rs885951 G T 0.40 0.48 4083 Intron 1 G A 0.06 0.13
-1691 5' rs3132519 G A 0.40 0.36 4202 Intron 1 C T 0.02 0.00
-1676 5' rs3094190 T C 0.44 0.36 4231 Intron 1 rs3132526 A G 0.40 0.46
-1671 5' G A 0.00 0.02 4284 Intron 1 T G 0.00 0.09
-1650 5' rs1265159 C T 0.21 0.23 4285 Intron 1 + - 0.08 0.17
-1611 5' rs3132520 G A 0.40 0.55 4322 Intron 1 rs1265163 G C 0.17 0.20
-1566 5' rs28383834 -4 + 0.04 0.09 4466 Exon 16 rs3130932 T G 0.23 0.33
-1107 5' rs1108746 G T 0.11 0.10 4515 Exon 16 rs9501063 C G 0.15 0.00
-1093 5' rs885952 G A 0.43 0.55 4539 Exon 16 C T 0.06 0.13
-1055 5' rs879882 G A 0.50 0.21 4746 Intron 2 A G 0.06 0.13
-985 5' rs5875289 - + 0.17 0.17 4787 Intron 2 rs9281233 + - 0.23 0.33
-734 5' rs17197220 A G 0.04 0.04 4834 Intron 2 + - 0.35 0.33
-643 5' rs9263818 G T 0.17 0.14 4908 Intron 2 rs2106074 T C 0.23 0.33
-520 5' rs9263817 C T 0.17 0.14 5724 Intron 4 rs3064866 + - 0.23 0.33
-513 5' rs3094191 A G 0.10 0.23 5763 Intron 4 rs9263795 A G 0.00 0.13
-400 5' rs9263816 C A 0.17 0.14 5770 Intron 4 rs2394882 G T 0.23 0.33
-310 5' rs17190839 C T 0.15 0.00 6005 Exon 5 rs1061118, rs17197178 T C 0.25 0.25
-75 5' rs17197199 G A 0.15 0.00 6116 3' UTR rs3734864 G A 0.02 0.00
21 Exon 15 rs2077010 G A 0.42 0.50 6279 3' rs13409 C T 0.41 0.48
27 Exon 15 rs1265160 C T 0.15 0.20 6334 3' rs3130933 G A 0.00 0.11
291 Exon 1 rs1062630 C T 0.20 0.20 6466 3' T C 0.02 0.00
561 Intron 1 rs3130504 A T 0.17 0.20 6582 3' rs17190811 T A 0.06 0.13
594 Intron 1 rs3094192 C G 0.17 0.20 6623 3' C T 0.02 0.00
600 Intron 1 G A 0.25 0.17 6712 3' rs9501062 A G 0.12 0.00
601 Intron 1 C T 0.04 0.00 6808 3' G T 0.17 0.20
624 Intron 1 rs3094193 A C 0.33 0.33 6810 3' A T 0.17 0.20
639 Intron 1 rs3132522 G A 0.17 0.20 6813 3' + - 0.17 0.20
653 Intron 1 rs9263811 G A 0.17 0.13 6822 3' G A 0.02 0.00
663 Intron 1 C G 0.19 0.04 6851 3' rs3132528 A G 0.17 0.20
679 Intron 1 - + 0.42 0.50 7144 3' rs17190798 T A 0.06 0.14
683 Intron 1 T C 0.04 0.07 7211 3' rs17190783 T C 0.06 0.14
690 Intron 1 C T 0.19 0.04 7555 3' rs17190776 C T 0.06 0.13
709 Intron 1 T G 0.02 0.00 7599 3' rs1044870 G A 0.17 0.13
742 Intron 1 C T 0.10 0.00 7660 3' rs1841 T C 0.04 0.07
770 Intron 1 rs9263810 C G 0.17 0.13 7827 3' rs1419881 T C 0.44 0.50
1424 Intron 1 A G 0.02 0.00 7845 3' rs9501503 G C 0.02 0.00
1570 Intron 1 rs3132523 G A 0.17 0.20 7918 Exon7 rs1065461 G A 0.17 0.20
1650 Intron 1 rs17840029 T C 0.04 0.04 8128 Intron7 G A 0.02 0.00
1688 Intron 1 rs3132524 G A 0.17 0.20 8169 Intron7 rs3216869 + - 0.12 0.00
1Polymorphism sites are named according to the number of bases from the first transcription start site, 2National Center for Biotechnology Information (NCBI) rsnumbers are included if they have been previously published, 3AD, African-descent and ED, 
European-descent populations, 4 (-), deletion and (+), insertion polymorphisms. The (+) allele for each loci is as follows: -1566 = G, -985 = G, 679 = TCTG, 2665 = G, 2679 = AG, 3679 = GAG, 3738 = TG, 4284 = CTC, 4787 = CT, 4834 = GGGCTT, 5724 = 
TC, 6813 = A, 8169 = GAAG, 5Exon for POU5F1 isoform 1 only, 6Exon for POU5F1 isoform 2 only, 7Loci are 3' of the POU5F1 gene, and in the exon/intron of the flanking TCF 19 gene.BMC Genetics 2008, 9:15 http://www.biomedcentral.com/1471-2156/9/15
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(rs17197199), 21 G > A (rs2077010), 27 C > T
(rs1265160), 291 C > T(rs1062630), 5763 A > G
(rs9263795), 5770 G > T (rs2394882), and 6005 T > C
(rs1061118, rs17197178).
Linkage structure
Both populations displayed high haplotype diversity. In
total, there were 41 haplotypes inferred among the 94
chromosomes, or 47 individuals, represented. Twenty-
one (51%) of the haplotypes were unique to the AD pop-
ulation, 12 (29%) were unique to the ED population, and
8 (20%) of the haplotypes were shared across both popu-
lations (Table 2). A majority of the haplotypes carried
exclusively in either the AD or ED populations were only
observed once, 76% and 50%, respectively; the majority
(75%) of haplotypes carried in both populations had a
frequency ≥ 0.05. Three of the most common haplotypes
accounted for 28% of all haplotypes. The non-synony-
mous SNP in the start codon of POU5F1 isoform 2 was
carried in 18 haplotypes. Analysis of the recombination
rates revealed a potential recombination hotspot in the
ED population in intron 1 between loci -1755 T > G and -
1694 G > T. Recombination between these two loci
exceeded the background rate of recombination by a fac-
tor of 11 (data not shown).
The phylogenetic analysis of POU5F1 haplotypes shows
that the earliest division of the haplotype tree into two
large clades differentiate between one clade that mainly
consists of haplotypes from AD individuals, and another
that contains a mix of haplotypes from AD and ED indi-
viduals (Figure 2). Although several clades have mixed AD
and ED haplotypes, often the nearest neighboring haplo-
types are from the same population.
In the AD population there were 68 polymorphisms with
a MAF ≥ 0.10. With an r2 threshold of 0.80, these poly-
morphisms can be grouped into 17 clusters (9 of which
are singles) which can be tagged by an equal number of
tagging polymorphisms (Figure 3). In the ED population,
among the 70 polymorphisms with a MAF ≥ 0.10, 10 tag-
ging polymorphisms can be selected to capture the clus-
ters of correlated polymorphisms, of which 2 are
singletons. For a combined population of AD and ED
individuals, 24 tagging polymorphisms can tag the clus-
ters of correlated loci, due to overlap in the correlation
patterns between the AD and ED populations.
The International HapMap Project genotyped 36 POU5F1
loci that were polymorphic in samples from either the
population of European-decent (CEU) or Yoruban-decent
from Nigeria (YRI), or both. With an r2 threshold of 0.80,
HapMap POU5F1 polymorphisms with a MAF ≥ 0.10 can
be clustered into 9 groups in the CEU population and 12
groups in the YRI population.
Discussion
POU5F1 has a critical role in regulating pluripotency in
embryonic development [1-3,10-12]. In non-diseased tis-
sue and tissue from non-germ cell tumors, POU5F1
expression is virtually undetectable [4,5,7,13]. However,
the observation that POU5F1 is expressed in TGCC [14-
16], and may be somatically mutated in other cancers
[17], suggests that genetic variation in POU5F1 could con-
ceivably alter protein expression or activity, thereby influ-
encing risk of TGCC. In this paper, we have identified the
presence of 38 new polymorphisms, and verified the pres-
ence of 68 previously reported polymorphisms, in the
African-descent and European-decent populations in the
gene region encompassing POU5F1. A majority of the 40
polymorphisms contained in the NCBI SNP database that
Physical map of POU5F1 Figure 1
Physical map of POU5F1. A. Lines indicate locations of polymorphisms and octagons indicate locations of two unscanned 
segments of intron 1. B. Predictions of evolutionarily conserved elements in the gene using sequences from 17 vertebrates by 
PhastCons (Siepel et al., 2005). C. Untranslated regions (thin bars), exons (thick bars), and introns (black hatched lines) of 
POU5F1 and a flanking gene, TCF 19. Direction of transcription is indicated by the arrows.
Table 2: Distribution of POU5F1 haplotypes by population and 
haplotyope frequency
Population1 Haplotype frequency, N(%) Total N
0.02 0.04 ≥ 0.05
AD, only 16(76) 1 (5) 4 (19) 21
ED, only 6 (50) 4 (33) 2 (17) 12
AD and ED 0 2 (25) 6 (75) 8
1AD, African-descent, ED, European-decent populationsBMC Genetics 2008, 9:15 http://www.biomedcentral.com/1471-2156/9/15
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we did not detect were those associated with a low level of
internal validation (i.e. single submission or mutation on
a single chromosome), and thus most likely represent
genotyping errors or somatic mutations. Our observation
that the AD population was more polymorphic compared
to the ED population is consistent with prior reports [18],
however the observed SNP density (1 in 103 bp in the AD
population and 1 in 127 bp in the ED population) of
POU5F1 is higher than most genes [19-21].
We analyzed linkage disequilibrium patterns in POU5F1,
and identified clusters of correlated polymorphisms. The
NCBI SNP Database contains records for at least one pos-
sible tagging polymorphism for all but three of the 17 AD
clusters (A15–A17, Figure 3), and for all 10 ED clusters.
The HapMap Project genotyped approximately 1/3 the
number of polymorphisms as we identified in our re-
sequencing of the POU5F1 region in populations with
similar ancestry. They also observed a lower number of
unique clusters of correlate polymorphisms, which sug-
gests a less-than-complete coverage of POU5F1 LD pat-
terns by the HapMap Project. Furthermore, our AD
population is an admixed population and likely exhibits
a more complex pattern of LD compared to the YRI Hap-
Map population.
Within groups of correlated polymorphisms, selecting
tagging polymorphisms should not only consider the
level of correlation with other polymorphisms, but also
the extent to which a particular SNP may have functional
consequences. Several polymorphisms identified in
POU5F1 make them potentially interesting candidate pol-
ymorphisms. For example, we confirmed the existence of
a common SNP at position 4466 T > G (rs3130932) that
produces a non-synonymous change in the initiating
methionine (ATG → AGG) of POU5F1 isoform 2 [7]. Car-
riers of this variant cannot express POU5F1 isoform 2.
Alternative mRNA splicing is a process that is signaled by
the recognition of specific nucleotide sequences on either
the proximal or distal end of the splice junction, and
results in structural and functional diversity in proteins.
Few data exist on expression of the different POU5F1 iso-
forms in germ cells or germ cell tumor tissue, since most
expression studies to date have not discriminated between
the two isoforms. In human preimplantation embryos,
however, the two isoforms displayed temporal and spatial
Phylogenic tree of the 41 observed POU5F1 haplotypes Figure 2
Phylogenic tree of the 41 observed POU5F1 haplotypes. The tree was created using the neighbor-joining method in 
MEGA (version 3.1). The branch line length is proportional to the number of nucleotide differences between haplotypes from 
the root. The polymorphisms in each haplotype are ordered from 5' to 3', in the same order as the polymorphisms listed in 
Table 2, and the first site in each triplet is listed as the column heading. The (.) indicates that the allele is the same as the first 
haplotype in the tree. The (-) indicates a deletion, and the (+) indicated an insertion. Haplotypes unique to the African-descent 
population are indicated by the white triangles, those unique to the European-descent population are indicated by white 
squares, and those observed in both populations are indicated by black circles.BMC Genetics 2008, 9:15 http://www.biomedcentral.com/1471-2156/9/15
Page 6 of 10
(page number not for citation purposes)
Visual genotypes for POU5F1 polymorphisms in African-descent (A.) and European-descent (B.) populations Figure 3
Visual genotypes for POU5F1 polymorphisms in African-descent (A.) and European-descent (B.) populations. 
Subjects (rows) and polymorphisms (columns, details for each polymorphism appear in Table 2) are clustered by groups of cor-
related polymorphisms (r2 ≥ 0.80), indicated by black lines. Colored squares represent genotypes at each polymorphic site: red 
= heterozygotes, yellow = homozygotes (minor allele), blue = homozygotes (major allele), and grey = missing data. Asterisks 
denote best choices for tagging polymorphism(s) based on r2 values with other polymorphisms within the cluster. Only poly-
morphisms with a minor allele frequency ≥ 0.10 are included.BMC Genetics 2008, 9:15 http://www.biomedcentral.com/1471-2156/9/15
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differences in expression [22]. While isoform 1 is
expressed in the nucleus of compacted embryos and blas-
tocysts, isoform 2 expression was only weakly detected in
the periphery, or cytoplasm, of zygotes suggesting that the
isoform 2 may have other functions beyond transcription
activation [22].
Other potentially interesting regions of the gene are evo-
lutionarily conserved elements. POU5F1 expression is
thought to be driven by a promoter lacking a typical TATA
box, and having at least one distal and one proximal
enhancer that are maintained in conserved regions [23].
Within this promoter region, there are four regions of
homology between species with 66% to 94% conserva-
tion of bases [24]. We observed 3 SNPs mapping to these
conserved regions, -2482 C > T, -1892 C > T, and -75 G >
A with minor allele frequencies of 0.08, 0.02, and 0.15 in
the AD population and no nucleotide variation in the ED
population. If the presence of these variant alleles disrupts
binding of regulatory elements, and therefore reduces
POU5F1 expression, these variants may help to explain
part of the lower risk of TGCC observed in the AD popu-
lation [25].
One limitation of our study is that our population was too
small to identify rare polymorphisms reliably. However,
by studying 46 ED chromosomes and 48 AD chromo-
somes, we have 90% power to detect polymorphisms with
a minor allele frequency of at least 0.05 in each popula-
tion [26]. Thus, we have excellent power to detect com-
mon variation, which is generally the most useful for
typical genetic association studies that involve hundreds,
as opposed to thousands, of cases. However, we did not
scan two intronic segments, totaling 1 kilobase pairs
(kbs), for genetic variants. NCBI contains records for 24
polymorphisms mapping to these intronic regions, so it is
possible that we have missed some common variants that
existed in our study population in these regions, and also
that these variants tag unique patterns of variation that we
did not identify. A second limitation is that we only stud-
ied two populations, and our observed variation and link-
age disequilibrium patterns may not extend to individuals
in other populations, for example Asians. The HapMap
Project, which includes Japanese, Chinese, African, and
CEPH samples, shows that allele frequencies and linkage
disequilibrium patterns for POU5F1 polymorphisms vary
between populations, indicating that future resequencing
projects in other population may be needed.
Further studies are also needed to evaluate the functional
relevance of these polymorphisms, as well as investiga-
tions into whether these polymorphisms impact TGCC
risk or other phenotypes related to stem cell pluripotency.
Conclusion
This paper provides the first comprehensive report of
sequence variation in an 11.3 kbs region containing
POU5F1. We identified 106 polymorphisms, 36% of
which have not previously been reported. Several poly-
morphisms were identified in conserved regions, includ-
ing a non-synonymous polymorphism occurring in one-
quarter and one-third of the AD and ED populations,
respectively, that causes a methionine to arginine amino
acid substitution in an alternative start codon of POU5F1.
Linkage disequilibrium patterns differed by population,
however, a much smaller subset of polymorphisms may
be used to tag the observed common genetic variation in
either population with little loss of information, amount-
ing to a 4.0- and 7.0-fold gain in efficiency in the AD and
ED populations, respectively.
Methods
Samples
Twenty-four samples from unrelated individuals of Afri-
can-descent (AD) and 23 Centre d'Etude de Polymor-
phism Humain (CEPH) samples from unrelated
individuals of European-descent (ED), were obtained
from the Coriell Repository (Camden, New Jersey, USA)
and used for gene re-sequencing (sample identification
numbers for the AD population: NA17101, NA17102,
NA17103, NA17104, NA17105, NA17106, NA17107,
NA17108, NA17109, NA17110, NA17111, NA17112,
NA17113, NA17114, NA17115, NA17116, NA17133,
NA17134, NA17135, NA17136, NA17137, NA17138,
NA17139, NA17140; for the ED population: NA12560,
NA12547, NA10845, NA10853, NA10860, NA10830,
NA10842, NA10851, NA07349, NA10857, NA10858,
NA10848, NA12548, NA10844, NA10854, NA10861,
NA10831, NA10843, NA10850, NA07348, NA10852,
NA06990, NA07019).
Gene re-sequencing
Approximately 11.3 kpb of DNA containing the POU5F1
gene (3.0 kbp 5' of the gene, 6.0 kbp of the gene, and 2.3
kbp 3' of the gene) were amplified and scanned for varia-
tion using high-throughput methods. Primers were
designed for 25 amplicons of approximately 600 bp each
covering all exons, flanking regions, and most intronic
regions (Table 3). To ensure that POU5F1 was targeted
specifically, and not a pseudogene, extra care was taken to
design primers and amplicons using Agencourt's proprie-
tary modeling software. During the modeling stage, an in
silico ePCR check was done on each amplicon to verify
that each amplicon only had one ePCR hit. A positive
ePCR hit is defined as having the forward and reverse
primers match the genomic sequence exactly without a
single mismatch. Two segments of the first intron totaling
approximately 1 kb were not scanned. Universal forward
(GTAAAACGACGGCCAGT) or reverse (CAG-BMC Genetics 2008, 9:15 http://www.biomedcentral.com/1471-2156/9/15
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GAAACAGCTATGACC) sequences were added to the 5'
end of primers to generate fragments compatible with
dye-primer florescence-based sequencing. Overlapping
primers were designed to identify any instances of primer
specific amplification. PCR products were purified utiliz-
ing Agencourt's solid phase reversible immobilization
reagent, AMPure. Bi-directional (forward and reverse)
sequencing of PCR products was performed using the ABI
BigDye Terminator v3.1 cycle sequencing chemistry, fol-
lowed by purification using Agencourt CleanSeq reagent.
Determination of sequencing products was performed
using ABI 3700/3730 capillary sequencers. Sequencing
reactions were performed twice in each direction, result-
ing in four traces for each amplicon.
Analysis
Polymorphism identification
Chromatograms of fluorescence-based sequences were
compared across all samples to identify polymorphic loci
and to determine which individuals were heterozygous or
homozygous for the common or variant alleles using
PolyPhred [27]. PolyPhred uses the base calls and peak
information provided by Phred [28,29] and the sequence
alignments provided by Phrap. PolyPhred detects a heter-
ozygous locus by a significant drop in the height of a flu-
orescence peak along with the presence of a second
fluorescence peak, but ignores regions of poor sequence
quality, such as the ends of amplicons, to reduce the
number of miscalled sites. In addition to using PolyPhred,
all sequences were visually inspected in Consed [30] by a
data analyst for confirmation. The polymorphisms were
named according to distance in bases from the first trans-
lational start, according to our reference sequence [See
Additional file 1], 3,055 bases downstream of our re-
sequencing start site.
We accessed the National Center for Biotechnology Infor-
mation (NCBI) SNP Database on November 13, 2006 [8],
and compared the polymorphisms identified from our re-
sequencing to those contained in the database.
Comparative genomics
We analyzed the polymorphism data using the University
of California Santa Cruz (UCSC) Genome Browser
human assembly from March 2006 [31] to identify the
location of SNPs in relation to conserved elements within
and flanking POU5F1. We used the 'most conserved' track
setting which shows predictions of conserved regions
using sequences from 17 vertebrates produced by Phast-
Cons software [32]. PhastCons uses a phylogenetic hid-
den Markov model and a maximum-likelihood approach
to produce conservation scores for each nucleotide of the
Table 3: Nucleotide sequences for the forward (F) and reverse (R) primers used in the POU5F1 sequencing reactions
Oligo Name Sequence Oligo Name Sequence
01F GCTGCTCATCTCACCTCTCC 14R AGGTGATTGTTTGAGCAAAGG
01R AAACACCTTCCCCAATTTCC 15F AGATGGAGTCTCACTCTGTC
02F GCTCATATCCAGCCACAAGG 15R TTGAGCCCAAGAGTTAGAAAGC
02R AATACCTGCCACAGGTCTGC 16F GGCCTCCCAAAGTGAAGG
03F ACCAGGCCCCATAATCTACC 16R TGCATACACACAAACACAGC
03R TCATGCTGCTGGTCTAGTGC 17F GATGTCAGGGCTCTTTGTCC
04F GAGCCCCCAGACTTACCC 17R AAAGAAGATAGTTCATTTAATACCTGCAAAA
04R AGAGGGGGCAGCTCTAACC 18F GATCTCAGCTCACTGCAACC
05F CTCCTCTGCGTCTTTCTGC 18R TCGGGATTCAAGAACCTACG
05R CTGCACATCAGGTTCCTTGC 19F TGGGTGAATGACATTTGTGG
06F CTCCCAGGCTTCTTTGAACC 19R CGTTTGGCTGAATACCTTCC
06R AATCCTAGGCATTCCCATCC 20F TCTGGGAAGAGGTGGTAAGC
07F GTGCTTATGGCTGTTGATGC 20R CTGGTTCGCTTTCTCTTTCG
07R GTCTGTGGAAGGGGAAAACC 21F AAAGCTTGCCCTTGTCACC
08F GAGCAGAAGGATTGCTTTGG 21R CCTCTCGTTGTGCATAGTCG
08R GGCCTTGGAAGCTTAGCC 22F GAATGTCCAAGCAGAGTCAGG
09F TGAGTAGTCCCTTCGCAAGC 22R GATGTGGGATTAAAATCAAGAGC
09R ACCCTGCCTGCTCCTCTCC 23F AGGAATTGGGAACACAAAGG
10F AGGAGGCAAGTGAGCTTCG 23R TCTGGTTGGGGTGATCTAGG
10R GGTAAACCCAGCTCACAACG 24F GTTCAGAGCTGGCTTTTTGC
11F GGGTAAAAACAGTGCTCATTCC 24R GAAGATTTATTTACAGGCTTCACC
11R CCCCCTAGGAGATTTTGTGC 25F GCCATCACACTGGTAAACTGC
12F ATAATGGCTGGCAATTGTGG 25R GCACCTATCAGTTGCAAAAGC
12R CTGAGGATGACTGGGTTTGG 26F GGTCGCTACGATTTTGTTGG
13F CACCCTCAAGGCTTAAATGC 26R CCTGGGTTCAGTGTGATGG
13R TGAGAGTTTCGCTTTTGTTGC 27F CGCTGCTGTGTCTACTCATGG
14F AAAAAAGGTGAGGCTAGGTGC 27R AACCGGAGTGAGCATGTCCBMC Genetics 2008, 9:15 http://www.biomedcentral.com/1471-2156/9/15
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alignment, which can be interpreted as the probability
that the nucleotide is in a conserved element. Each pre-
dicted conserved element was assigned a log-odds score
indicating how much more likely it is under the conserved
phylogenetic model than the nonconserved model.
Linkage structure
Haplotypes were inferred separately for the AD and ED
populations using PHASE (version 2.1) software, which
uses a Bayesian statistical method [33]. Posterior recombi-
nation parameters, obtained from the general model for
varying recombination rate in PHASE, were used to deter-
mine the presence and location of any potential recombi-
nation hotspots defined by a substantial difference in
recombination between two neighboring loci and the
background recombination rate [34]. Ancestral relation-
ships between inferred haplotypes from both populations
were examined using MEGA (version 3.1) software [35],
using the neighbor-joining method [36]. The square of
Pearson's correlation coefficient (r2) for pairwise compar-
isons of biallelic polymorphisms was used to determine
the extent to which polymorphic loci provide redundant
genotype information. Groups of correlated polymor-
phisms were identified through a binning algorithm using
a threshold value of r2 ≥ 0.80 between one polymorphism
and a maximum number of other polymorphisms, sepa-
rately for the AD and ED populations, using the LDSelect
version 1.0 program [37]. LDSelect also identifies desira-
ble tagging polymorphisms for each group of polymor-
phisms based on the r2 statistic between polymorphisms
within a group. In addition, the combined population of
AD and ED individuals was analyzed using the multi-
PopTagSelect version 1.1 program, which identifies the
smallest number of maximally informative tagging poly-
morphisms to capture correlation patterns in both popu-
lations [38].
Within the region we resequenced, the International Hap-
Map Project, data release 21, phase II, [9] has genotyped
31 polymorphisms in several populations (including 90
Caucasian individuals from Utah, USA, in the CEPH col-
lection). We  compared the tagging polymorphisms iden-
tified from our genotype data to that  of two populations
in the HapMap project.
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